 |
PDBsum entry 1rf2
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Toxin
|
 |
|
Title:
|
 |
Cholera toxin b-pentamer complexed with bivalent nitrophenol- galactoside ligand bv4
|
|
Structure:
|
 |
Cholera toxin b protein (ctb). Chain: d, e, f, g, h. Engineered: yes
|
|
Source:
|
 |
Vibrio cholerae. Organism_taxid: 666. Gene: ctxb. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
1.35Å
|
R-factor:
|
0.134
|
R-free:
|
0.174
|
|
|
Authors:
|
 |
J.C.Pickens,D.D.Mitchell,J.Liu,X.Tan,Z.Zhang,C.L.Verlinde,W.G.Hol, E.Fan
|
Key ref:
|
 |
J.C.Pickens
et al.
(2004).
Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer.
Chem Biol,
11,
1205-1215.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Nov-03
|
Release date:
|
26-Oct-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01556
(CHTB_VIBCH) -
Cholera enterotoxin subunit B from Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
124 a.a.
103 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Chem Biol
11:1205-1215
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Nonspanning bivalent ligands as improved surface receptor binding inhibitors of the cholera toxin B pentamer.
|
|
J.C.Pickens,
D.D.Mitchell,
J.Liu,
X.Tan,
Z.Zhang,
C.L.Verlinde,
W.G.Hol,
E.Fan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A series of bivalent ligands of varying length were synthesized to inhibit the
receptor-binding process of cholera toxin. Competitive surface receptor binding
assays showed that significant potency gains relative to the constituent
monovalent ligands were achieved independently from the ability of the extended
bivalent ligands to span binding sites within the toxin pentamer. Several models
that could account for the unexpected improvement in IC(50) values are examined,
taking into account crystallographic analysis of each ligand in complex with the
toxin pentamer. Evidence is presented that steric blocking at the receptor
binding surface may play a role. The results of our study suggest that the use
of relatively short, "nonspanning" bivalent ligands, or monovalent
ligands of similar topology and bulk may be an effective way of blocking the
interaction of multimeric proteins with their cell surface receptors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Previously Studied Monovalent Ligands to CT and
LT and Chemical Structure of Newly Synthesized Bivalent Ligands
BV1–BV4
|
 |
Figure 5.
Figure 5. Electron Density and Fitted Model(A) Electron
density and model for BV1 in complex with CTB[5]. Electron
density is contoured at 2σ in a σ[A]-weighted (mFo–DFc)
difference map.(B) Electron density and model for BV4 in complex
with CTB[5]. Electron density is contoured at 3σ in a
σ[A]-weighted (mFo-DFc) difference map.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Chem Biol
(2004,
11,
1205-1215)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Sisu,
A.J.Baron,
H.M.Branderhorst,
S.D.Connell,
C.A.Weijers,
R.de Vries,
E.D.Hayes,
A.V.Pukin,
M.Gilbert,
R.J.Pieters,
H.Zuilhof,
G.M.Visser,
and
W.B.Turnbull
(2009).
The influence of ligand valency on aggregation mechanisms for inhibiting bacterial toxins.
|
| |
Chembiochem,
10,
329-337.
|
 |
|
|
|
|
 |
J.Liu,
D.Begley,
D.D.Mitchell,
C.L.Verlinde,
G.Varani,
and
E.Fan
(2008).
Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions.
|
| |
Chem Biol Drug Des,
71,
408-419.
|
 |
|
|
|
|
 |
K.A.Schug,
M.D.Joshi,
P.Frycák,
N.M.Maier,
and
W.Lindner
(2008).
Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.
|
| |
J Am Soc Mass Spectrom,
19,
1629-1642.
|
 |
|
|
|
|
 |
P.Rai,
D.Vance,
V.Poon,
J.Mogridge,
and
R.S.Kane
(2008).
Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids.
|
| |
Chemistry,
14,
7748-7751.
|
 |
|
|
|
|
 |
S.Liu,
and
K.L.Kiick
(2008).
Architecture Effects on the Binding of Cholera Toxin by Helical Glycopolypeptides.
|
| |
Macromolecules,
41,
764-772.
|
 |
|
|
|
|
 |
B.D.Polizzotti,
R.Maheshwari,
J.Vinkenborg,
and
K.L.Kiick
(2007).
Effects of Saccharide Spacing and Chain Extension on Toxin Inhibition by Glycopolypeptides of Well-Defined Architecture.
|
| |
Macromolecules,
40,
7103-7110.
|
 |
|
|
|
|
 |
B.D.Polizzotti,
and
K.L.Kiick
(2006).
Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers.
|
| |
Biomacromolecules,
7,
483-490.
|
 |
|
|
|
|
 |
Y.Wang,
and
K.L.Kiick
(2005).
Monodisperse protein-based glycopolymers via a combined biosynthetic and chemical approach.
|
| |
J Am Chem Soc,
127,
16392-16393.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |